BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3777615)

  • 1. Perfluorocarbons as blood substitutes.
    Waxman K
    Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
    Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
    Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorocarbon infusion in bleeding patients refusing blood transfusions.
    Waxman K; Tremper KK; Cullen BF; Mason GR
    Arch Surg; 1984 Jun; 119(6):721-4. PubMed ID: 6610401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
    Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.
    Spruell RD; Ferguson ER; Clymer JJ; Vicente WV; Murrah CP; Holman WL
    ASAIO J; 1995; 41(3):M636-41. PubMed ID: 8573883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorocarbon emulsions: methodology to assess efficacy.
    Rosen AL; Sehgal LR; Gould SA; Sehgal H; Dalton L; Rice CL; Moss GS
    Crit Care Med; 1982 Mar; 10(3):149-54. PubMed ID: 7060386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Red cell substitutes: perfluorocarbon emulsions and hemoglobin solutions].
    Rémy B; Deby-Dupont G; D'Ans V; Ernest P; Lamy M
    Ann Fr Anesth Reanim; 1999 Feb; 18(2):211-24. PubMed ID: 10207594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The initial response of blood leukocytes to incubation with perfluorocarbon blood substitute emulsions.
    McDonagh PF; Wilson DS
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):439-47. PubMed ID: 7493065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions.
    Remy B; Deby-Dupont G; Lamy M
    Br Med Bull; 1999; 55(1):277-98. PubMed ID: 10695091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the mass transfer of blood gases in hypoxia during infusion of and emulsion of perfluorocarbons].
    Kuznetsova IN; Gerbut KA; Liagushkina LV
    Fiziol Zh SSSR Im I M Sechenova; 1986 Feb; 72(2):231-8. PubMed ID: 3084306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorocarbon-based red blood cell substitutes.
    Biro GP
    Transfus Med Rev; 1993 Apr; 7(2):84-95. PubMed ID: 8481603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport.
    Faithfull NS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):797-804. PubMed ID: 1391514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.
    Flaim SF
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1043-54. PubMed ID: 7849908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Artificial oxygen carriers as an alternative to red blood cell transfusion].
    Habler O; Pape A; Meier J; Zwissler B
    Anaesthesist; 2005 Aug; 54(8):741-54. PubMed ID: 16021390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
    Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
    N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.